Dialytic Management of Acute Kidney Injury and Intensive Care Unit Nephrology

Comprehensive Clinical Nephrology: Fourth Edition

Volumn , Issue , 2010, Pages 843-852

  Marshall, Mark R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882836883     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05876-6.00070-8     Document Type: Chapter

References (40)

1. Bagshaw SM, George C, Bellomo R Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007, 11:R68.
2. De Vriese AS, Colardyn FA, Philippé JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10:846-853.
3. Joannes-Boyau O, Honore PM, Boer W, Collin V Are the synergistic effects of high-volume haemofiltration and enhanced adsorption the missing key in sepsis modulation?. Nephrol Dial Transplant 2009, 24:354-357.
4. Bagshaw SM, Uchino S, Bellomo R, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009, 24:129-140.
5. Bouman C, Oudemans-Van Straaten HM, Tijssen JG, et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 2002, 30:2205-2211.
6. Kellum JA, Mehta RL, Levin A, et al. Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am Soc Nephrol 2008, 3:887-894.
7. Ponikvar JB, Rus RR, Kenda RB, et al. Low-flux versus high-flux synthetic dialysis membrane in acute renal failure: Prospective randomized study. Artif Organs 2001, 25:946-950.
8. Paganini E, Sandy D, Moreno L, et al. The effect of sodium and ultrafiltration modelling on plasma volume and haemodynamic stability in intensive care patients receiving haemodialysis for acute renal failure: A prospective, stratified, randomized, cross-over study. Nephrol Dial Transplant 1996, 11(Suppl):32-37.
9. Tonelli M, Astephen P, Andreou P, et al. Blood volume monitoring in intermittent hemodialysis for acute renal failure. Kidney Int 2002, 62:1075-1080.
10. Marshall M, Golper T Intermittent hemodialysis. Intensive Care In Nephrology 2006, 181-198. Taylor & Francis, Oxon, UK. P. Murray, H. Brady, J. Hall (Eds.).
11. Paganini EP, Tapolyai M, Goormastic M, et al. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 1996, 28(Suppl):S81-S89.
12. Schiffl H, Lang S, Fischer R Daily hemodialysis and the outcomes of acute renal failure. N Eng J Med 2002, 346:305-310.
13. Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359:7-20.
14. Casino F, Lopez T The equivalent renal urea clearance: A new parameter to assess dialysis. Nephrol Dial Transplant 1996, 11:1574-1581.
15. Frankenfield D, Reynolds HN, Wiles CE, et al. Urea removal during continuous hemodiafiltration. Crit Care Med 1993, 22:407-412.
16. Kudoh Y, Iimura O Slow continuous hemodialysis-new therapy for acute renal failure in critically ill patients-Part 1. Theoretical considerations and new technique. Jpn Circ J 1988, 52:1171-1182.
17. Brunet S, Leblanc M, Geadah D, et al. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999, 34:486-492.
18. Troyanov S, Cardinal J, Geadah D, et al. Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant 2003, 18:961-966.
19. Ronco C, Bellomo R Complications with renal replacement therapy. Am J Kidney Dis 1996, 28(Suppl 3):S100-S104.
20. Manns M, Sigler MH, Teehan BP Continuous renal replacement therapies: An update. Am J Kidney Dis 1998, 32:185-207.
21. Ronco C Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol 1993, 40:187-198.
22. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000, 356:26-30.
23. Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006, 70:1312-1317.
24. Tolwani AJ, Campbell RC, Stofan BS, et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008, 19:1233-1238.
25. Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 361:1627-1638.
26. Leblanc M, Moreno L, Robinson OP, et al. Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure. Am J Kidney Dis 1995, 26:910-917.
27. Marshall MR, Golper TA, Shaver MJ, et al. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001, 60:777-785.
28. Oliver M Acute dialysis catheters. Semin Dial 2001, 14:432-435.
29. Leblanc M, Fedak S, Mokris G, Paganini E Blood recirculation in temporary central catheters for acute hemodialysis. Clin Nephrol 1996, 45:315-319.
30. Centers for Disease Control and Prevention Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002, 51(RR-10).
31. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Vascular Access, 2000. Am J Kidney Dis 2001, 37(Suppl 1):S137-S181.
32. Pannu N, Klarenbach S, Wiebe N, et al. Renal replacement therapy in patients with acute renal failure: A systematic review. JAMA 2008, 299:793-805.
33. Mehta RL, McDonald BR, Aguilar MM, Ward DM Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990, 38:976-981.
34. Hoffmann JN, Hartl WH, Deppisch R, et al. Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 1995, 48:1563-1570.
35. Palsson R, Niles JL Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999, 55:1991-1997.
36. Tolwani AJ, Campbell RC, Schenk MB, et al. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001, 60:370-374.
37. Tobe SW, Aujla P, Walele AA, et al. A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care 2003, 18:121-129.
38. Mitchell A, Daul AE, Beiderlinden M, et al. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin Nephrol 2003, 59:106-114.
39. Swartz R, Pasko D, O'Toole J, Starmann B Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 2004, 61:134-143.
40. Gupta M, Wadhwa NK, Bukovsky R Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Am J Kidney Dis 2004, 43:67-73.